Crinetics Pharmaceuticals Inc buy Oppenheimer Holdings Inc.
Start price
18.03.24
/
50%
€35.20
Target price
18.03.25
€49.66
Performance (%)
18.75%
Price
31.05.24
€41.00
Summary
This prediction is currently active. The prediction currently has a performance of 18.75%. This prediction currently runs until 18.03.25. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Crinetics Pharmaceuticals Inc | -6.393% | -6.393% |
iShares Core DAX® | -0.552% | 3.281% |
iShares Nasdaq 100 | -1.415% | 4.535% |
iShares Nikkei 225® | -0.877% | -1.739% |
iShares S&P 500 | -0.415% | 3.239% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $54.00 price target on the stock, up previously from $48.00.
Ratings data for CRNX provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€42.20
20.03.24
20.03.24
€50.64
20.03.25
20.03.25
-2.84%
31.05.24
31.05.24
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€38.00
29.02.24
29.02.24
€44.35
28.02.25
28.02.25
7.89%
31.05.24
31.05.24
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€25.00
11.09.23
11.09.23
€42.75
11.09.24
11.09.24
64.00%
31.05.24
31.05.24
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€16.10
30.08.23
30.08.23
-
30.08.24
30.08.24
154.66%
31.05.24
31.05.24